2008
DOI: 10.1159/000155745
|View full text |Cite
|
Sign up to set email alerts
|

Cysteinyl Leukotrienes Induce Macrophage Inflammatory Protein-1 in Human Monocytes/Macrophages

Abstract: Background: Macrophage inflammatory protein-1α (MIP-1α) and MIP-1β are known for their chemotactic and proinflammatory effects on monocytes/macrophages which have a cysteinyl leukotriene 1 (CysLT1) receptor. Methods: We examined MIP-1α and MIP-1β production stimulated by CysLTs (LTC4, LTD4, and LTE4) in THP-1 cells, a human monocytic leukemia cell line, and peripheral blood mononuclear cells (PBMCs). Moreover, we examined the inhibitory effect of pranlukast, a CysLT<… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 52 publications
0
5
0
Order By: Relevance
“…This shows that PRK downregulates the 5‐lipoxygenase pathway, thereby reducing the Mtb survival and dissemination within the macrophages. Also, PRK treatment causes a notable decline in the CysLTR1 transcript levels in the macrophages, along with downregulation in the MCP‐1 levels, a downstream effector of CysLTR1 signaling (Ichiyama et al , , ) (Fig G and H). The decrease in the CysLTR1 gene expression could be due to two reasons: (i) since the leukotriene biosynthesis is inhibited, CysLTR1 is downregulated in the absence of its ligand (leukotrienes), (ii) since CysLTR1 levels are upregulated upon Mtb infection, PRK‐mediated reduction in Mtb within macrophages will lead to reduction in the CysLTR1 levels as well.…”
Section: Resultsmentioning
confidence: 88%
“…This shows that PRK downregulates the 5‐lipoxygenase pathway, thereby reducing the Mtb survival and dissemination within the macrophages. Also, PRK treatment causes a notable decline in the CysLTR1 transcript levels in the macrophages, along with downregulation in the MCP‐1 levels, a downstream effector of CysLTR1 signaling (Ichiyama et al , , ) (Fig G and H). The decrease in the CysLTR1 gene expression could be due to two reasons: (i) since the leukotriene biosynthesis is inhibited, CysLTR1 is downregulated in the absence of its ligand (leukotrienes), (ii) since CysLTR1 levels are upregulated upon Mtb infection, PRK‐mediated reduction in Mtb within macrophages will lead to reduction in the CysLTR1 levels as well.…”
Section: Resultsmentioning
confidence: 88%
“…PGs E 2 and I 2 , and cysteinyl leukotrienes). In turn, these eicosanoids can modulate chemokine production in monocytes and macrophages (Hashimoto et al ., ; Ichiyama et al ., ; Kuo et al ., ; Buenestado et al ., ; Tsai et al ., ). Furthermore, 15‐HETE can be also produced via COX‐dependent pathways (Levy et al ., ).…”
Section: Discussionmentioning
confidence: 99%
“…Monocytes/macrophages stimulated with cysteinyl leukotrienes (cysLTs) activated the transcription factor nuclear factor kappa B (NFjB)-and induced monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 [35][36][37]. In addition, cysLTs and TNF-alpha induced matrix metalloproteinase-9 (MMP-9) production in monocyte/ macrophages [38].…”
Section: Discussionmentioning
confidence: 99%